Agfa Props Cardio Imaging Platform With Heartlab Purchase, Gains 250 Sites
This article was originally published in The Gray Sheet
Executive Summary
Heartlab CEO Robert Petrocelli, a physicist and computer expert, will head Agfa's cardiology business following a $132.5 mil. acquisition by the diversified imaging giant
You may also be interested in...
Agfa/Mitra
IMPAX picture archiving and communications system (PACS) maker Agfa acquires privately held, Waterloo, Ontario-based OEM software supplier Mitra. Mortsel, Belgium-based diversified imaging firm Agfa-Gevaert N.V.'s Agfa HealthCare unit notes that Mitra "has played an integral role in the development and success of Agfa's IMPAX PACS solutions for the past ten years" and "this next step in the relationship is the best way to ensure that the mission we have pursued in the past is continued, enhanced and expanded." Terms of the deal were not disclosed...
As Casgevy, Lyfgenia Launches Proceed, CRISPR And bluebird bio CEOs Reassure
The CEOs of bluebird bio and CRISPR Therapeutics hope to inspire investor confidence that their gene-based therapies for sickle cell disease and beta thalassemia will be widely reimbursed in the US and EU.
Japan Regulatory Update: Revised Law Widens RWD Scope, Price Revisions/Listings
Japan now allows pseudonymized personal data for medical use under a licensing system for wider use of real-world data. Meanwhile, a national cost-effectiveness assessment scheme has slashed reimbursement prices for Lagevrio and Kerendia, and Alexion’s Voydeya has been added to the reimbursement tariff.